Lucius Tirzepatide (also known as Tirzepatide) – Buy online

USD 87.50

Sold 2,700+
Special Offer

Offline Hong Kong pharmacy with 100% genuine product guarantee

Key Highlights

Tirzepatide received FDA approval in May 2022 as a prescription therapy targeting both GIP and GLP-1 receptors for type 2 diabetes management.

Service Promise

Direct from JapanLicensed PharmacyPharmacist CheckedEditable in Admin

Specifications

Specification
15mg,5mg,10mg
Manufacturer
Lucius Pharmaceuticals
Shipping
Hong Kong

10000 in stock

Product Info

English Name
Tirzepatide
Generic Name
Tirzepatide

Specifications

Specification
15mg,5mg,10mg
Manufacturer
Lucius Pharmaceuticals
Shipping
Hong Kong

Full Details

How It Works

GIP GLP-1 C20 , GIP GLP-1 , GIP GLP-1 GIP GLP-1 ,

Pharmacology

12.1 How It Works GIP GLP-1 C20 , GIP GLP-1 , GIP GLP-1 GIP GLP-1 ,

Dosage

2.1 MOUNJARO 2.5 mg [ Dosage (2.2)] , [ Precautions (5.6) (6.1)] 2.5 mg , 4 , 5 mg , 4 , 2.5 mg

Precautions

5.1 C 2 , , C [ (13.1)] MOUNJARO C , (MTC), C MOUNJARO MTC , MEN 2 MOUNJARO MTC ,

Contraindications

MOUNJARO MTC , 2 MEN 2 [ Precautions 5.1 ] MOUNJARO MOUNJARO , [ Precautions 5.4 ]

Drug Interactions

7.1 MOUNJARO , , [ Precautions (5.3)] 7.2 MOUNJARO , MOUNJARO , MOUNJARO

Adverse Reactions

Description C [ Precautions (5.1)] [ Precautions (5.2)] [ Precautions (5.3)] [ Precautions (5.4)] [ Precautions (5.5)] [ Precautions (5.6)] [ Precautions (5.7)] [ Precautions (5.8)]

Storage

16.1 MOUNJARO , , 4 1 1 1 , 4 NDC 1 NDC 2.5 mg/0.5 mL 0002-1506-80 0002-1152-01 5 mg/0.5 mL 0002-1495-80 0002-1243-01 7.5 mg/0.5 mL 0002-148

Indications

Used as an adjunct to diet and exercise to improve glycemic control in adults and children aged 10 years and older with type 2 diabetes.

Package Insert

Ingredients

11 ZEPBOUND , , , GIP GLP-1 GIP , 2 13 Aib ,C , 20 , 1,20- 4813.53 Da, C225H348N48O68 ZEPBOUND 0.5 mL 2.5 mg 5 mg 7.5 mg 10 mg 12.5 mg 15 mg , 4.1 mg 0.7 mg

Dosage

2.1 MOUNJARO 2.5 mg [ Dosage (2.2)] , [ Precautions (5.6) (6.1)] 2.5 mg , 4 , 5 mg , 4 , 2.5 mg

Adverse Reactions

Description C [ Precautions (5.1)] [ Precautions (5.2)] [ Precautions (5.3)] [ Precautions (5.4)] [ Precautions (5.5)] [ Precautions (5.6)] [ Precautions (5.7)] [ Precautions (5.8)]

Contraindications

MOUNJARO MTC , 2 MEN 2 [ Precautions 5.1 ] MOUNJARO MOUNJARO , [ Precautions 5.4 ]

Precautions

5.1 C 2 , , C [ (13.1)] MOUNJARO C , (MTC), C MOUNJARO MTC , MEN 2 MOUNJARO MTC ,

Use in Pregnancy and Lactation

8.1 , ZEPBOUND ZEPBOUND , 1-800-LillyRx (1-800-545-5979) , , ZEPBOUND “ Precautions”

Drug Interactions

7.1 MOUNJARO , , [ Precautions (5.3)] 7.2 MOUNJARO , MOUNJARO , MOUNJARO

Clinical Pharmacology

12 12.1 How It Works GIP GLP-1 C20 , GIP GLP-1 , GIP GLP-1 GIP GLP-1 GLP-1 , GIP

Storage

16.1 MOUNJARO , , 4 1 1 1 , 4 NDC 1 NDC 2.5 mg/0.5 mL 0002-1506-80 0002-1152-01 5 mg/0.5 mL 0002-1495-80 0002-1243-01 7.5 mg/0.5 mL 0002-148

Product Reviews (14)

Filter: All Reviews
4.8★★★★★
14 customer reviews11 verified purchases
+o***e· 3周前
★★★★
+t***3· 1个月前
Verified Purchase
★★★★★

Description

How It Works

GIP GLP-1 C20 , GIP GLP-1 , GIP GLP-1 GIP GLP-1 ,

Pharmacology

12.1 How It Works GIP GLP-1 C20 , GIP GLP-1 , GIP GLP-1 GIP GLP-1 ,

Dosage

2.1 MOUNJARO 2.5 mg [ Dosage (2.2)] , [ Precautions (5.6) (6.1)] 2.5 mg , 4 , 5 mg , 4 , 2.5 mg

Precautions

5.1 C 2 , , C [ (13.1)] MOUNJARO C , (MTC), C MOUNJARO MTC , MEN 2 MOUNJARO MTC ,

Contraindications

MOUNJARO MTC , 2 MEN 2 [ Precautions 5.1 ] MOUNJARO MOUNJARO , [ Precautions 5.4 ]

Drug Interactions

7.1 MOUNJARO , , [ Precautions (5.3)] 7.2 MOUNJARO , MOUNJARO , MOUNJARO

Adverse Reactions

Description C [ Precautions (5.1)] [ Precautions (5.2)] [ Precautions (5.3)] [ Precautions (5.4)] [ Precautions (5.5)] [ Precautions (5.6)] [ Precautions (5.7)] [ Precautions (5.8)]

Storage

16.1 MOUNJARO , , 4 1 1 1 , 4 NDC 1 NDC 2.5 mg/0.5 mL 0002-1506-80 0002-1152-01 5 mg/0.5 mL 0002-1495-80 0002-1243-01 7.5 mg/0.5 mL 0002-148

Indications

Used as an adjunct to diet and exercise to improve glycemic control in adults and children aged 10 years and older with type 2 diabetes.